Cutaneous Reactions to Chemotherapy Drugs
The Art of Consultation
Arch Dermatol. 2003;139:77-81.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
THE PURPOSE of this article is to review information on cutaneous reactions to chemotherapy, in particular those for which the dermatologist is likely be called in consultation and asked to comment on regarding the safety and feasibility of readministration of a particular drug. Emphasis is also placed on information that may be used to mitigate these adverse mucocutaneous effects. Pertinent articles on cutaneous reactions to chemotherapy were collected from the literature through a MEDLINE search from 1966 through 2001. Two categories of articles were chosen: those that pertained to 3 well-recognized cutaneous reaction patterns and those that pertained to 5 specific drugs that cause particularly frequent or important cutaneous reactions. Where known, mechanisms of toxicity and its prevention are reviewed.
Arch Dermatol. 2003;139:77-81
There are new chemotherapeutic agents and several older ones that manifest a variety of cutaneous reactions. Sometimes these reactions can be dose limiting to further administration of . . . [Full Text of this Article] NEUTROPHILIC ECCRINE HIDRADENITIS (DRUG-INDUCED ECCRINE HIDRADENITIS)
ACRAL ERYTHEMA
INFLAMMATION OF ACTINIC KERATOSES
BLEOMYCIN
HYDROXYUREA
DOCETAXEL
POLYETHYLENE GLYCOL–COATED LIPOSOMAL DOXORUBICIN
THALIDOMIDE
COMMENT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Inflammation of Actinic Keratoses During Capecitabine Therapy
Lewis et al.
Arch Dermatol 2004;140:367-368.
FULL TEXT
|
